Credit Suisse Starts Aratana Therapeutics (PETX) at Outperform, $11 PT
Tweet Send to a Friend
Credit Suisse initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Outperform rating and a price target of $11.00.Analyst E ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
